These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 22960250)

  • 41. Changed conformation of mutant Tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of Tau-4R/2N transgenic mice.
    Terwel D; Lasrado R; Snauwaert J; Vandeweert E; Van Haesendonck C; Borghgraef P; Van Leuven F
    J Biol Chem; 2005 Feb; 280(5):3963-73. PubMed ID: 15509565
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combining P301L and S320F tau variants produces a novel accelerated model of tauopathy.
    Koller EJ; Gonzalez De La Cruz E; Machula T; Ibanez KR; Lin WL; Williams T; Riffe CJ; Ryu D; Strang KH; Liu X; Janus C; Golde TE; Dickson D; Giasson BI; Chakrabarty P
    Hum Mol Genet; 2019 Oct; 28(19):3255-3269. PubMed ID: 31261380
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Progressive neurodegeneration in C. elegans model of tauopathy.
    Miyasaka T; Ding Z; Gengyo-Ando K; Oue M; Yamaguchi H; Mitani S; Ihara Y
    Neurobiol Dis; 2005 Nov; 20(2):372-83. PubMed ID: 16242642
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Distribution of spleen tyrosine kinase and tau phosphorylated at tyrosine 18 in a mouse model of tauopathy and in the human hippocampus.
    Köhler C; Fuhr V; Dinekov M
    Brain Res; 2017 Dec; 1677():1-13. PubMed ID: 28919467
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Propagation of tau pathology in a model of early Alzheimer's disease.
    de Calignon A; Polydoro M; Suárez-Calvet M; William C; Adamowicz DH; Kopeikina KJ; Pitstick R; Sahara N; Ashe KH; Carlson GA; Spires-Jones TL; Hyman BT
    Neuron; 2012 Feb; 73(4):685-97. PubMed ID: 22365544
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pathogenic tau does not drive activation of the unfolded protein response.
    Pitera AP; Asuni AA; O'Connor V; Deinhardt K
    J Biol Chem; 2019 Jun; 294(25):9679-9688. PubMed ID: 31053641
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Progressive Motor Deficit is Mediated by the Denervation of Neuromuscular Junctions and Axonal Degeneration in Transgenic Mice Expressing Mutant (P301S) Tau Protein.
    Yin Z; Valkenburg F; Hornix BE; Mantingh-Otter I; Zhou X; Mari M; Reggiori F; Van Dam D; Eggen BJL; De Deyn PP; Boddeke E
    J Alzheimers Dis; 2017; 60(s1):S41-S57. PubMed ID: 28222529
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuropathological correlates of structural and functional imaging biomarkers in 4-repeat tauopathies.
    Spina S; Brown JA; Deng J; Gardner RC; Nana AL; Hwang JL; Gaus SE; Huang EJ; Kramer JH; Rosen HJ; Kornak J; Neuhaus J; Miller BL; Grinberg LT; Boxer AL; Seeley WW
    Brain; 2019 Jul; 142(7):2068-2081. PubMed ID: 31081015
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeting tauopathy with engineered tau-degrading intrabodies.
    Gallardo G; Wong CH; Ricardez SM; Mann CN; Lin KH; Leyns CEG; Jiang H; Holtzman DM
    Mol Neurodegener; 2019 Oct; 14(1):38. PubMed ID: 31640765
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regenerating islet-derived 1α (REG-1α) protein increases tau phosphorylation in cell and animal models of tauopathies.
    Moussaed M; Huc-Brandt S; Cubedo N; Silhol M; Murat S; Lebart MC; Kovacs G; Verdier JM; Trousse F; Rossel M; Marcilhac A
    Neurobiol Dis; 2018 Nov; 119():136-148. PubMed ID: 30092268
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tau deposition drives neuropathological, inflammatory and behavioral abnormalities independently of neuronal loss in a novel mouse model.
    Cook C; Kang SS; Carlomagno Y; Lin WL; Yue M; Kurti A; Shinohara M; Jansen-West K; Perkerson E; Castanedes-Casey M; Rousseau L; Phillips V; Bu G; Dickson DW; Petrucelli L; Fryer JD
    Hum Mol Genet; 2015 Nov; 24(21):6198-212. PubMed ID: 26276810
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Improved long-term potentiation and memory in young tau-P301L transgenic mice before onset of hyperphosphorylation and tauopathy.
    Boekhoorn K; Terwel D; Biemans B; Borghgraef P; Wiegert O; Ramakers GJ; de Vos K; Krugers H; Tomiyama T; Mori H; Joels M; van Leuven F; Lucassen PJ
    J Neurosci; 2006 Mar; 26(13):3514-23. PubMed ID: 16571759
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tauopathy-associated tau modifications selectively impact neurodegeneration and mitophagy in a novel C. elegans single-copy transgenic model.
    Guha S; Fischer S; Johnson GVW; Nehrke K
    Mol Neurodegener; 2020 Nov; 15(1):65. PubMed ID: 33168053
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anticholinergics boost the pathological process of neurodegeneration with increased inflammation in a tauopathy mouse model.
    Yoshiyama Y; Kojima A; Itoh K; Uchiyama T; Arai K
    Neurobiol Dis; 2012 Jan; 45(1):329-36. PubMed ID: 21889983
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Exacerbation of C1q dysregulation, synaptic loss and memory deficits in tau pathology linked to neuronal adenosine A2A receptor.
    Carvalho K; Faivre E; Pietrowski MJ; Marques X; Gomez-Murcia V; Deleau A; Huin V; Hansen JN; Kozlov S; Danis C; Temido-Ferreira M; Coelho JE; Mériaux C; Eddarkaoui S; Gras SL; Dumoulin M; Cellai L; ; Landrieu I; Chern Y; Hamdane M; Buée L; Boutillier AL; Levi S; Halle A; Lopes LV; Blum D
    Brain; 2019 Nov; 142(11):3636-3654. PubMed ID: 31599329
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neurofibrillary tangle formation by introducing wild-type human tau into APP transgenic mice.
    Umeda T; Maekawa S; Kimura T; Takashima A; Tomiyama T; Mori H
    Acta Neuropathol; 2014 May; 127(5):685-98. PubMed ID: 24531886
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Selective Disruption of Inhibitory Synapses Leading to Neuronal Hyperexcitability at an Early Stage of Tau Pathogenesis in a Mouse Model.
    Shimojo M; Takuwa H; Takado Y; Tokunaga M; Tsukamoto S; Minatohara K; Ono M; Seki C; Maeda J; Urushihata T; Minamihisamatsu T; Aoki I; Kawamura K; Zhang MR; Suhara T; Sahara N; Higuchi M
    J Neurosci; 2020 Apr; 40(17):3491-3501. PubMed ID: 32265258
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Glutamatergic nervous system degeneration in a C. elegans Tau
    Choudhary B; Mandelkow E; Mandelkow EM; Pir GJ
    Neurobiol Dis; 2018 Sep; 117():189-202. PubMed ID: 29894752
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neuroprotective effects of low fat-protein diet in the P301L mouse model of tauopathy.
    Buccarello L; Grignaschi G; Di Giancamillo A; Domeneghini C; Melcangi RC; Borsello T
    Neuroscience; 2017 Jun; 354():208-220. PubMed ID: 28456717
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pin1 has opposite effects on wild-type and P301L tau stability and tauopathy.
    Lim J; Balastik M; Lee TH; Nakamura K; Liou YC; Sun A; Finn G; Pastorino L; Lee VM; Lu KP
    J Clin Invest; 2008 May; 118(5):1877-89. PubMed ID: 18431510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.